MedTrace Logo

Brief Alcohol Treatment for Women Veterans in Primary Care - Open Trial

NCT07782307 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-08-24

No results posted yet for this study

Summary

The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves an open trial phase to test the intervention with a small number of participants and revise the intervention based on experience and feedback. The main questions it aims to answer are:

* Is the treatment feasible and acceptable to women Veteran primary care patients?
* Can the treatment help reduce alcohol use, alcohol-related problems, and improve quality of life? Researchers will deliver the intervention to women Veterans with unhealthy alcohol use in primary care. Participants will be asked to participate in the new behavioral treatment and attend 2 appointments to answer questions about their alcohol use, quality of life, other mental health symptoms, and what they thought of their behavioral treatment.

Conditions

  • Unhealthy Alcohol Use

Interventions

BEHAVIORAL

Brief, Integrated Intervention for Women Veterans with Unhealthy Alcohol Use in Primary Care

The intervention consists of 4-9 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. It includes 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use that have been adapted from existing evidence-based treatments in integrated primary care and specialty care. Participants may elect to attend up to 5 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns, including mood, trauma, sleep, and pain.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Syracuse VA Medical Center

    lead FED

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2027-09-30
Completion
2027-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07782307 on ClinicalTrials.gov